STERIS Corporation is a leading global provider of infection prevention and other procedural products and services. The company is focused primarily on Healthcare, Pharmaceutical and Medical Device Customers. Their mission is to help Customers create a healthier and safer world by providing innovative healthcare and life science products and services, including capital equipment, consumables, and services for sterilization, surgical tables, lights, and connectivity solutions.
Serves as the primary center for corporate management, strategic planning, global operations oversight, administrative functions, and key research and development initiatives.
Modern corporate campus designed to foster innovation and collaboration, likely featuring advanced office spaces, meeting facilities, and potentially R&D laboratories or demonstration areas for its technologies.
The work culture at STERIS HQ is likely focused on innovation, quality, customer satisfaction, and teamwork, reflecting its critical role in the healthcare and life sciences industries. There's an emphasis on continuous improvement and adherence to regulatory standards.
The Mentor headquarters is significant as it anchors STERIS's global strategy, product development, and market leadership in infection prevention and procedural solutions. It's the nerve center for a company operating in over 100 countries.
STERIS supports Customers worldwide through a robust network of manufacturing facilities, sales offices, service centers, and R&D sites. Key functions supported globally include product development, advanced manufacturing of medical devices and consumables, contract sterilization services (AST), equipment installation and maintenance, and comprehensive customer support across the Healthcare, Pharmaceutical, and Medical Device sectors in North America, Europe, Asia-Pacific, Latin America, and other international markets.
5960 Heisley Road
Mentor
Ohio
USA
Address: IDA Business & Technology Park, Srah, Tullamore, Co. Offaly, Ireland
Serves as a major hub for manufacturing, research and development, and distribution for the European market, ensuring compliance with regional regulations and meeting local customer needs.
Address: Steris House, Hornbeam Park, Harrogate, North Yorkshire, HG2 8NB, United Kingdom (Note: Harrogate is a major UK hub; Leicester also has operations, but Harrogate is prominent for UK HQ functions)
Manages commercial activities, technical support, and customer relations for the United Kingdom, ensuring localized service delivery and market penetration.
Address: Address details vary by specific facility, Plymouth houses key operations.
Supports specific product divisions or operational functions within the North American market, contributing to innovation and supply chain efficiency.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, STERIS' leadership includes:
STERIS has been backed by several prominent investors over the years, including:
STERIS has maintained a relatively stable core executive team, with notable board-level appointments to strengthen governance and strategic oversight.
Discover the tools STERIS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
STERIS Corporation typically utilizes common corporate email formats. The most prevalent formats include combinations of first name, last name, and initials.
[first]_[last]@steris.com (e.g. john_doe@steris.com) or [first_initial][last]@steris.com (e.g. jdoe@steris.com)
Format
john_smith@steris.com
Example
85%
Success rate
STERIS Investor Relations / Business Wire • May 21, 2024
STERIS plc (NYSE: STE) today announced that its Board of Directors has authorized a quarterly dividend of $0.52 per share. The dividend is payable June 20, 2024, to shareholders of record at the close of business on June 3, 2024....more
STERIS Investor Relations / Business Wire • May 8, 2024
STERIS plc (NYSE: STE) announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Fourth quarter revenues increased 5% to $1.4 billion, with constant currency organic revenue growth of 5%. Net income was $159.7 million, or $1.57 per diluted share....more
STERIS Investor Relations / Business Wire • February 29, 2024
STERIS plc (NYSE: STE) announced the appointment of Mohit Uberoi to its Board of Directors, effective February 28, 2024. Mr. Uberoi brings significant experience in the healthcare industry, particularly in medical technology and digital health....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including STERIS, are just a search away.